Table 2.
Rates (x1000 x month) and HRs of access to hospital care, outpatient specialist visits and death for convalescent COVID-19 patients and the control group, overall and according to Charlson Index and hospitalisation for COVID-19
| Rates x 1000 (95% CI) |
HR (95% CI) |
HR in Charlson Index=0 (95%CI) | HR in Charlson Index≥1 (95%CI) | HR hospitalised COVID-19 vs control (95% CI) | HR non-hospitalised COVID-19 vs control (95% CI) | ||
| Non-surgical h admissions | Control | 3.8 (3.5 to 4.1) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 5.2 (4.9 to 5.5) | 1.38 (1.25 to 1.52) | 1.11 (0.97 to 1.27) | 1.83 (1.73 to 2.14) | 3.16 (2.53 to 3.95) | 1.12 (1.0 to 1.29) | |
| H admissions for respiratory disease | Control | 0.3 (0.2 to 0.4) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 0.7 (0.6 to 0.9) | 2.09 (2.07 to 4.09) | 6.69 (2.84 to 15.70) | 2.30 (1.57 to 3.36) | 4.19 (2.41 to 7.30) | 1.91 (1.27 to 2.89) | |
| H admissions for heart disease | Control | 0.4 (0.3 to 0.5) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 0.8 (0.7 to 1.0) | 1.93 (1.46 to 2.55) | 1.49 (1.37 to 1.62) | 2.38 (1.62 to 3.5) | 3.56 (2.02 to 6.25) | 1.44 (1.04 to 1.97) | |
| Accesses to emergency room |
Control |
7.4 (7.1 to 7.7) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 9.5 (9.2 to 9.8) | 1.36 (1.29 to 1.42) | 1.32 (1.25 to 1.39) | 1.51 (1.36 to 1.66) | 2.05 (1.79 to 2.35) | 1.23 (1.18 to 1.29) | |
| Death | Control | 0.19 (0.16 to 0.22) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 0.41 (0.35 to 0.47) | 3.69 (2.73 to 4.98) | 3.07 (1.73 to 5.47) | 3.68 (2.59 to 5.23) | 6.20 (3.50 to 10.10) | 2.87 (2.01 to 4.11) | |
| Outpatient specialist visits | |||||||
| Pneumology | Control | 2.1 (1.9 to 2.4) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 5.2 (4.9 to 5.6) | 2,45 (2.17 to 2.76) | 3.35 (3.09 to 3.65) | 1.53 (1.36 to 1.71) | 4.44 (3.36 to 5.86) | 1.83 (1.61 to 2.09) | |
| Cardiology | Control | 6.8 (6.4 to 7.2) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 9.7 (9.2 to 10.2) | 1.44 (1.33 to 1.55) | 1.53 (1.36 to 1.71) | 1.23 (1.07 to 1.41) | 1.72 (1.43 to 2.06) | 1.28 (1.18 to 1.39) | |
| Neurology | Control | 4.8 (4.5 to 5.2) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 6.0 (5.7 to 6.4) | 1,25 (1.14 to 1.36) | 1.22 (1.1 to 1.35) | 1.37 (1.12 to 1.68) | 1.46 (1.10 to 1.92) | 1.17 (1.06 to 1.28) | |
| Rheumatology | Control | 3.2 (3.0 to 3.5) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 3.8 (3.5 to 4.1) | 1,17 (1.05 to 1.31) | 1.19 (1.04 to 1.36) | 1.15 (0.93 to 1.42) | 1.09 (0.78 to 1.51) | 1.23 (1.09 to 1.38) | |
| Gastroenterology | Control | 1.7 (1.5 to 1.9) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 1.8 (1.6 to 2.0) | 1.04 (0.89 to 1.22) | 1.0 (0.84 to 1.20) | 1.21 (0.85 to 1.73) | 1.25 (0.68 to 2.32) | 0.97 (0.82 to 1.14) | |
| Mental health | Control | 1.2 (1.0 to 1.4) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 1.1 (0.9 to 1.2) | 0.91 (0.75 to 1.10) | 0.90 (0.73 to 1.11) | 0.97 (0.54 to 1.74) | 1.38 (0.59 to 3.24) | 0.93 (0.76 to 1.14) | |
| Dermatology | Control | 8.9 (8.5 to 9.4) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 9.5 (9.0 to 9.9) | 1.06 (0.99 to 1.14) | 1.06 (0.98 to 1.14) | 1.10 (0.92 to 1.31) | 0.95 (0.72 to 1.26) | 1.07 (1.00 to 1.15) | |
| Endocrinology | Control | 8.5 (8.0 to 8.9) | 1 | 1 | 1 | 1 | 1 |
| COVID-19 | 11.0 (10.5 to 11.5) | 1,30 (1.21 to 1.39) | 1.28 (1.18 to 1.40) | 1.34 (1.19 to 1.50) | 2.05 (1.74 to 2.41) | 1.11 (1.03 to 1.20) |